全球免疫組織化學市場 2024-2028

免疫組織化學市場預計在 2022-2027 年期間成長 10.6713 億美元，預測期內複合年成長率為 7.52%。

該報告包括對免疫組織化學市場的總體分析、市場規模/預測、趨勢、成長促進因素、挑戰以及涵蓋約 25 家供應商的供應商分析。

它提供了對當前市場狀況、最新趨勢和促進因素以及整體市場環境的最新分析。該市場的推動因素包括全球癌症患者數量的增加、人口老化的加劇以及參與企業之間的併購。

該研究認為免疫組織化學過程的自動化和數位化是未來幾年推動免疫組織化學市場成長的關鍵因素之一。此外，個人化醫療需求的成長和醫療保健產業投資的增加也將帶來巨大的市場需求。

目錄

第1章執行摘要

• 市場概況

第2章 市場狀況

• 市場生態系統

第3章 市場規模評估

• 市場定義
• 細分市場分析
• 2023 年市場規模
• 2023-2028年市場展望

第4章 市場規模表現

• 2018-2018年全球免疫組織化學市場
• 2018-2018 年按應用分類的細分市場分析
• 2018-2018 年最終用戶細分分析
• 2018-2018年區域細分分析
• 2018-2018 年國家細分分析

第5章五力分析

• 五力摘要
• 買方議價能力
• 供應商的議價能力
• 新進入者的威脅
• 替代品的威脅
• 競爭威脅
• 市場狀況

第6章市場區隔：按應用

• 細分市場
• 比較：按應用
• 診斷應用：2023-2028 年市場規模與預測
• 研究應用：2023-2028 年市場規模與預測
• 法醫學應用：2023-2028 年市場規模與預測
• 市場機會：依應用分類

第7章市場區隔：依最終用戶

• 細分市場
• 比較：按最終用戶
• 醫院與診斷實驗室：2023-2028 年市場規模與預測
• 學術研究院：2023-2028年市場規模及預測
• 其他：2023-2028年市場規模與預測
• 市場機會：依最終用戶分類

第8章 客戶狀況

• 客戶狀況概覽

第9章 地區情勢

• 區域細分
• 區域比較
• 北美：2023-2028 年市場規模與預測
• 歐洲：2023-2028 年市場規模與預測
• 亞洲：2023-2028年市場規模與預測
• 世界其他地區：2023-2028 年市場規模與預測
• 美國：2023-2028 年市場規模與預測
• 德國：2023-2028 年市場規模與預測
• 法國：2023-2028年市場規模與預測
• 中國：2023-2028年市場規模及預測
• 英國：2023-2028 年市場規模與預測
• 市場機會：依地區狀況

第 10 章 促進因素、挑戰與趨勢

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場趨勢

第11章 供應商情況

• 概述
• 供應商情況
• 混亂的情況
• 產業風險

第12章供應商分析

• 交易廠商
• 供應商市場定位
• Agilent Technologies Inc.
• Bio SB
• Biocare Medical LLC
• BioGenex Laboratories Inc.
• CANDOR Bioscience GmbH
• Cell Signaling Technology Inc.
• Danaher Corp.
• Elabscience Biotechnology Inc.
• F. Hoffmann La Roche Ltd.
• Lunaphore Technologies SA
• Merck KGaA
• Miltenyi Biotec BV and Co. KG
• SAKURA SEIKI Co. Ltd.
• Takara Holdings Inc.
• Thermo Fisher Scientific Inc.

第13章附錄

The immunohistochemistry market is forecasted to grow by USD 1,067.13 mn during 2022-2027, accelerating at a CAGR of 7.52% during the forecast period. The report on the immunohistochemistry market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing number of cancer patients globally, the rising aging population, and mergers and acquisitions among immunohistochemistry market players.

Technavio's immunohistochemistry market is segmented as below:

By Application

• Diagnostic application
• Research application
• Forensic application

By End-user

• Hospitals and diagnostic laboratories
• Academic and research institutes
• Others

By Geographical Landscape

• North America
• Europe
• APAC
• Rest of World (ROW)

This study identifies the automation and digitalization of immunohistochemistry processes as one of the prime reasons driving the immunohistochemistry market growth during the next few years. Also, rise in demand for personalized medicine and increasing investment in healthcare industry will lead to sizable demand in the market.

The report on the immunohistochemistry market covers the following areas:

• Immunohistochemistry market sizing
• Immunohistochemistry market forecast
• Immunohistochemistry market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading immunohistochemistry market vendors that include Agilent Technologies Inc., Bio Rad Laboratories Inc., Bio SB, Bio Techne Corp., Biocare Medical LLC, BioGenex Laboratories Inc., CANDOR Bioscience GmbH, Cell Signaling Technology Inc., Danaher Corp., Eagle Biosciences Inc., Elabscience Biotechnology Inc., F. Hoffmann La Roche Ltd., Lunaphore Technologies SA, Merck KGaA, Miltenyi Biotec B.V. and Co. KG, PerkinElmer Inc., Takara Holdings Inc., Thermo Fisher Scientific Inc., PHC Holdings Corp., and SAKURA SEIKI Co. Ltd.. Also, the immunohistochemistry market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview

2 Market Landscape

• 2.1 Market ecosystem

3 Market Sizing

• 3.1 Market definition
• 3.2 Market segment analysis
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

• 4.1 Global immunohistochemistry market 2018 - 2018
• 4.2 Application Segment Analysis 2018 - 2018
• 4.3 End-user Segment Analysis 2018 - 2018
• 4.4 Geography Segment Analysis 2018 - 2018
• 4.5 Country Segment Analysis 2018 - 2018

5 Five Forces Analysis

• 5.1 Five forces summary
• 5.2 Bargaining power of buyers
• 5.3 Bargaining power of suppliers
• 5.4 Threat of new entrants
• 5.5 Threat of substitutes
• 5.6 Threat of rivalry
• 5.7 Market condition

6 Market Segmentation by Application

• 6.1 Market segments
• 6.2 Comparison by Application
• 6.3 Diagnostic application - Market size and forecast 2023-2028
• 6.4 Research application - Market size and forecast 2023-2028
• 6.5 Forensic application - Market size and forecast 2023-2028
• 6.6 Market opportunity by Application

7 Market Segmentation by End-user

• 7.1 Market segments
• 7.2 Comparison by End-user
• 7.3 Hospitals and diagnostic laboratories - Market size and forecast 2023-2028
• 7.4 Academic and research institutes - Market size and forecast 2023-2028
• 7.5 Others - Market size and forecast 2023-2028
• 7.6 Market opportunity by End-user

8 Customer Landscape

• 8.1 Customer landscape overview

9 Geographic Landscape

• 9.1 Geographic segmentation
• 9.2 Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• 9.4 Europe - Market size and forecast 2023-2028
• 9.5 Asia - Market size and forecast 2023-2028
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• 9.7 US - Market size and forecast 2023-2028
• 9.8 Germany - Market size and forecast 2023-2028
• 9.9 France - Market size and forecast 2023-2028
• 9.10 China - Market size and forecast 2023-2028
• 9.11 UK - Market size and forecast 2023-2028
• 9.12 Market opportunity By Geographical Landscape

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• 11.3 Landscape disruption
• 11.4 Industry risks

12 Vendor Analysis

• 12.1 Vendors covered
• 12.2 Market positioning of vendors
• 12.3 Agilent Technologies Inc.
• 12.4 Bio SB
• 12.5 Biocare Medical LLC
• 12.6 BioGenex Laboratories Inc.
• 12.7 CANDOR Bioscience GmbH
• 12.8 Cell Signaling Technology Inc.
• 12.9 Danaher Corp.
• 12.10 Elabscience Biotechnology Inc.
• 12.11 F. Hoffmann La Roche Ltd.
• 12.12 Lunaphore Technologies SA
• 12.13 Merck KGaA
• 12.14 Miltenyi Biotec B.V. and Co. KG
• 12.15 SAKURA SEIKI Co. Ltd.
• 12.16 Takara Holdings Inc.
• 12.17 Thermo Fisher Scientific Inc.

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• 13.3 Currency conversion rates for US$
• 13.4 Research methodology
• 13.5 List of abbreviations

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Application
• Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits18: Historic Market Size - Data Table on global immunohistochemistry market 2018 - 2018 ($ billion)
• Exhibits19: Historic Market Size - Application Segment 2018 - 2018 ($ billion)
• Exhibits20: Historic Market Size - End-user Segment 2018 - 2018 ($ billion)
• Exhibits21: Historic Market Size - Geography Segment 2018 - 2018 ($ billion)
• Exhibits22: Historic Market Size - Country Segment 2018 - 2018 ($ billion)
• Exhibits23: Five forces analysis - Comparison between 2023 and 2028
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits29: Chart on Market condition - Five forces 2023 and 2028
• Exhibits30: Chart on Application - Market share 2023-2028 (%)
• Exhibits31: Data Table on Application - Market share 2023-2028 (%)
• Exhibits32: Chart on Comparison by Application
• Exhibits33: Data Table on Comparison by Application
• Exhibits34: Chart on Diagnostic application - Market size and forecast 2023-2028 ($ billion)
• Exhibits35: Data Table on Diagnostic application - Market size and forecast 2023-2028 ($ billion)
• Exhibits36: Chart on Diagnostic application - Year-over-year growth 2023-2028 (%)
• Exhibits37: Data Table on Diagnostic application - Year-over-year growth 2023-2028 (%)
• Exhibits38: Chart on Research application - Market size and forecast 2023-2028 ($ billion)
• Exhibits39: Data Table on Research application - Market size and forecast 2023-2028 ($ billion)
• Exhibits40: Chart on Research application - Year-over-year growth 2023-2028 (%)
• Exhibits41: Data Table on Research application - Year-over-year growth 2023-2028 (%)
• Exhibits42: Chart on Forensic application - Market size and forecast 2023-2028 ($ billion)
• Exhibits43: Data Table on Forensic application - Market size and forecast 2023-2028 ($ billion)
• Exhibits44: Chart on Forensic application - Year-over-year growth 2023-2028 (%)
• Exhibits45: Data Table on Forensic application - Year-over-year growth 2023-2028 (%)
• Exhibits46: Market opportunity by Application ($ billion)
• Exhibits47: Data Table on Market opportunity by Application ($ billion)
• Exhibits48: Chart on End-user - Market share 2023-2028 (%)
• Exhibits49: Data Table on End-user - Market share 2023-2028 (%)
• Exhibits50: Chart on Comparison by End-user
• Exhibits51: Data Table on Comparison by End-user
• Exhibits52: Chart on Hospitals and diagnostic laboratories - Market size and forecast 2023-2028 ($ billion)
• Exhibits53: Data Table on Hospitals and diagnostic laboratories - Market size and forecast 2023-2028 ($ billion)
• Exhibits54: Chart on Hospitals and diagnostic laboratories - Year-over-year growth 2023-2028 (%)
• Exhibits55: Data Table on Hospitals and diagnostic laboratories - Year-over-year growth 2023-2028 (%)
• Exhibits56: Chart on Academic and research institutes - Market size and forecast 2023-2028 ($ billion)
• Exhibits57: Data Table on Academic and research institutes - Market size and forecast 2023-2028 ($ billion)
• Exhibits58: Chart on Academic and research institutes - Year-over-year growth 2023-2028 (%)
• Exhibits59: Data Table on Academic and research institutes - Year-over-year growth 2023-2028 (%)
• Exhibits60: Chart on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibits61: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibits62: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibits63: Data Table on Others - Year-over-year growth 2023-2028 (%)
• Exhibits64: Market opportunity by End-user ($ billion)
• Exhibits65: Data Table on Market opportunity by End-user ($ billion)
• Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits67: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits69: Chart on Geographic comparison
• Exhibits70: Data Table on Geographic comparison
• Exhibits71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibits72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibits73: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits74: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibits76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibits77: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibits80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibits81: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits87: Chart on US - Market size and forecast 2023-2028 ($ billion)
• Exhibits88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
• Exhibits89: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits90: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibits92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibits93: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits95: Chart on France - Market size and forecast 2023-2028 ($ billion)
• Exhibits96: Data Table on France - Market size and forecast 2023-2028 ($ billion)
• Exhibits97: Chart on France - Year-over-year growth 2023-2028 (%)
• Exhibits98: Data Table on France - Year-over-year growth 2023-2028 (%)
• Exhibits99: Chart on China - Market size and forecast 2023-2028 ($ billion)
• Exhibits100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
• Exhibits101: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits102: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits103: Chart on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibits104: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibits105: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits106: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits107: Market opportunity By Geographical Landscape ($ billion)
• Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• Exhibits109: Impact of drivers and challenges in 2023 and 2028
• Exhibits110: Overview on Criticality of inputs and Factors of differentiation
• Exhibits111: Overview on factors of disruption
• Exhibits112: Impact of key risks on business
• Exhibits113: Vendors covered
• Exhibits114: Matrix on vendor position and classification
• Exhibits115: Agilent Technologies Inc. - Overview
• Exhibits116: Agilent Technologies Inc. - Business segments
• Exhibits117: Agilent Technologies Inc. - Key news
• Exhibits118: Agilent Technologies Inc. - Key offerings
• Exhibits119: Agilent Technologies Inc. - Segment focus
• Exhibits120: Bio SB - Overview
• Exhibits121: Bio SB - Product / Service
• Exhibits122: Bio SB - Key offerings
• Exhibits123: Biocare Medical LLC - Overview
• Exhibits124: Biocare Medical LLC - Product / Service
• Exhibits125: Biocare Medical LLC - Key offerings
• Exhibits126: BioGenex Laboratories Inc. - Overview
• Exhibits127: BioGenex Laboratories Inc. - Product / Service
• Exhibits128: BioGenex Laboratories Inc. - Key offerings
• Exhibits129: CANDOR Bioscience GmbH - Overview
• Exhibits130: CANDOR Bioscience GmbH - Product / Service
• Exhibits131: CANDOR Bioscience GmbH - Key offerings
• Exhibits132: Cell Signaling Technology Inc. - Overview
• Exhibits133: Cell Signaling Technology Inc. - Product / Service
• Exhibits134: Cell Signaling Technology Inc. - Key offerings
• Exhibits135: Danaher Corp. - Overview
• Exhibits136: Danaher Corp. - Business segments
• Exhibits137: Danaher Corp. - Key news
• Exhibits138: Danaher Corp. - Key offerings
• Exhibits139: Danaher Corp. - Segment focus
• Exhibits140: Elabscience Biotechnology Inc. - Overview
• Exhibits141: Elabscience Biotechnology Inc. - Product / Service
• Exhibits142: Elabscience Biotechnology Inc. - Key offerings
• Exhibits143: F. Hoffmann La Roche Ltd. - Overview
• Exhibits144: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits145: F. Hoffmann La Roche Ltd. - Key news
• Exhibits146: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits147: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits148: Lunaphore Technologies SA - Overview
• Exhibits149: Lunaphore Technologies SA - Product / Service
• Exhibits150: Lunaphore Technologies SA - Key offerings
• Exhibits151: Merck KGaA - Overview
• Exhibits152: Merck KGaA - Business segments
• Exhibits153: Merck KGaA - Key news
• Exhibits154: Merck KGaA - Key offerings
• Exhibits155: Merck KGaA - Segment focus
• Exhibits156: Miltenyi Biotec B.V. and Co. KG - Overview
• Exhibits157: Miltenyi Biotec B.V. and Co. KG - Product / Service
• Exhibits158: Miltenyi Biotec B.V. and Co. KG - Key offerings
• Exhibits159: SAKURA SEIKI Co. Ltd. - Overview
• Exhibits160: SAKURA SEIKI Co. Ltd. - Product / Service
• Exhibits161: SAKURA SEIKI Co. Ltd. - Key offerings
• Exhibits162: Takara Holdings Inc. - Overview
• Exhibits163: Takara Holdings Inc. - Business segments
• Exhibits164: Takara Holdings Inc. - Key offerings
• Exhibits165: Takara Holdings Inc. - Segment focus
• Exhibits166: Thermo Fisher Scientific Inc. - Overview
• Exhibits167: Thermo Fisher Scientific Inc. - Business segments
• Exhibits168: Thermo Fisher Scientific Inc. - Key news
• Exhibits169: Thermo Fisher Scientific Inc. - Key offerings
• Exhibits170: Thermo Fisher Scientific Inc. - Segment focus
• Exhibits171: Inclusions checklist
• Exhibits172: Exclusions checklist
• Exhibits173: Currency conversion rates for US$
• Exhibits174: Research methodology
• Exhibits175: Validation techniques employed for market sizing
• Exhibits176: Information sources
• Exhibits177: List of abbreviations